Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 402
Ph III recruiting: 40
Growth YoY: +9.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 101–150 of 165 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04939272	Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma	active not recruiting	Phase 1 / Phase 2	8	City of Hope Medical CenterOTHER	1	Apr 20, 2026	clinicaltrials
NCT04189757	Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma	active not recruiting	Phase 2	9	M.D. Anderson Cancer CenterOTHER	1	Apr 16, 2026	clinicaltrials